212-681-1575
Sep

21

New Immune Cell May Predict Which Mesothelioma Pat...

Posted by

Label: Featured News


Oncologists sometimes check a mesothelioma patient‘s biomarkers, or genetic makeup, to determine which treatment will work best for the patient. However, the aggressive cancer can harbor multiple actionable biomarkers, still leaving the oncologist unsure as to which treatment to use.

Read Full Story

Want Specific topic updates?


With immunotherapy being a new, and sometimes experimental, treatment for mesothelioma patients, the benefits are still being uncovered. However, so too are the side effects and drawbacks. This month’s news has brought updates on both the pros and cons of

Read Full Story

Want Specific topic updates?


Immunotheraphy GE Healthcare Life Sciences

In December, MesotheliomaHelp reported that Roche’s immunotherapy drug atezolizumab (now known as TECENTRIQ), saw positive results in two Phase II clinical trials for non-small cell lung cancer patients (NSCLC). Now, Roche reports, in a separate trial the drug helped some

Read Full Story

Want Specific topic updates?